Treatment of Insomnia and Glucose Metabolism
NCT00724282
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Sleep
Insomnia
Insulin Resistance
Interventions
DRUG:
Eszopiclone
DRUG:
Placebo
Sponsor
University of Chicago